Temple University: 1st US patient treated with gimsilumab in trial for patients with COVID-19 and ARDS
by Press Release from Outbreak News Today on (#5275S)
Temple University Hospital has treated the first patient in the United States in the BREATHE clinical trial evaluating the impact of intravenous treatment with gimsilumab on mortality for patients with COVID-19 and acute respiratory distress syndrome (ARDS). Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School ["]
The post Temple University: 1st US patient treated with gimsilumab in trial for patients with COVID-19 and ARDS appeared first on Outbreak News Today.